The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acadia Pharmaceuticals Inc | COM | 004225108 | 961 | 42,773 | SH | SOLE | 42,773 | 0 | 0 | ||
Adamas Pharmaceuticals Inc | COM | 00548A106 | 8,832 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
Aerie Pharmaceuticals Inc | COM | 00771V108 | 802 | 14,779 | SH | SOLE | 14,779 | 0 | 0 | ||
Agios Pharmaceuticals Inc | COM | 00847X104 | 2,985 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
Alexion Pharmaceuticals Inc | COM | 015351109 | 8,074 | 72,441 | SH | SOLE | 72,441 | 0 | 0 | ||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 4,383 | 36,800 | SH | SOLE | 36,800 | 0 | 0 | ||
Amicus Therapeutics Inc | COM | 03152W109 | 881 | 58,600 | SH | SOLE | 58,600 | 0 | 0 | ||
Anaptysbio Inc | COM | 032724106 | 885 | 8,500 | SH | SOLE | 8,500 | 0 | 0 | ||
Array Biopharma Inc | COM | 04269X105 | 13,888 | 851,500 | SH | SOLE | 851,500 | 0 | 0 | ||
Avexis Inc | COM | 05366U100 | 2,100 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
Axogen Inc | COM | 05463X106 | 1,823 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BeiGene Ltd | SPONSORED ADR | 07725L102 | 1,596 | 9,500 | SH | SOLE | 9,500 | 0 | 0 | ||
Biogen Inc | COM | 09062X103 | 12,487 | 45,608 | SH | SOLE | 45,608 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COM | 09061G101 | 5,291 | 65,284 | SH | SOLE | 65,284 | 0 | 0 | ||
Bluebird Bio Inc | COM | 09609G100 | 3,413 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Celgene Corp | COM | 151020104 | 18,335 | 205,522 | SH | SOLE | 205,522 | 0 | 0 | ||
Clovis Oncology Inc | COM | 189464100 | 4,012 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
Cymabay Therapeutics Inc | COM | 23257D103 | 1,884 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
Deciphera Pharmaceuticals Inc | COM | 24344T101 | 1,542 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
Esperion Therapeutics Inc | COM | 29664W105 | 723 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 8,598 | 388,334 | SH | SOLE | 388,334 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 1,449 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd | SHS | M46135105 | 324 | 63,202 | SH | SOLE | 63,202 | 0 | 0 | ||
G1 Therapeutics Inc | COM | 3621LQ109 | 3,813 | 103,000 | SH | SOLE | 103,000 | 0 | 0 | ||
Gilead Sciences Inc | COM | 375558103 | 9,898 | 131,284 | SH | SOLE | 131,284 | 0 | 0 | ||
Globus Med Inc | COM | 379577208 | 1,445 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
GW Pharmaceuticals Plc | ADS | 36197T103 | 1,082 | 9,600 | SH | SOLE | 9,600 | 0 | 0 | ||
Halozyme Therapeutics Inc | COM | 40637H109 | 7,026 | 358,633 | SH | SOLE | 358,633 | 0 | 0 | ||
Horizon Pharma Plc | SHS | G4617B105 | 979 | 69,000 | SH | SOLE | 69,000 | 0 | 0 | ||
Incyte Corp | COM | 45337C102 | 6,081 | 72,975 | SH | SOLE | 72,975 | 0 | 0 | ||
Intersect Ent Inc | COM | 46071F103 | 1,452 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | ||
Ionis Pharmaceuticals Inc | COM | 462222100 | 5,576 | 126,500 | SH | SOLE | 126,500 | 0 | 0 | ||
Jazz Pharmaceuticals PLC | SHS USD | G50871105 | 2,867 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
Kalvista Pharmaceuticals Inc | COM | 483497103 | 3,008 | 322,436 | SH | SOLE | 322,436 | 0 | 0 | ||
Ligand Pharmaceuticals Inc | COM | 53220K504 | 6,936 | 42,000 | SH | SOLE | 42,000 | 0 | 0 | ||
Merus N V | COM | N5749R100 | 1,391 | 75,060 | SH | SOLE | 75,060 | 0 | 0 | ||
Molecular Templates Inc | COM | 608550109 | 1,978 | 247,587 | SH | SOLE | 247,587 | 0 | 0 | ||
Neurocrine Biosciences Inc | COM | 64125C109 | 12,770 | 154,000 | SH | SOLE | 154,000 | 0 | 0 | ||
Optinose Inc | COM | 68404V100 | 1,300 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
Paratek Pharmaceuticals Inc | COM | 699374302 | 1,346 | 103,500 | SH | SOLE | 103,500 | 0 | 0 | ||
Penumbra Inc | COM | 70975L107 | 1,618 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
Portola Pharmaceuticals Inc | COM | 737010108 | 784 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
Puma Biotechnology Inc | COM | 74587V107 | 2,312 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
Radius Health Inc | COM | 750469207 | 675 | 18,799 | SH | SOLE | 18,799 | 0 | 0 | ||
Regeneron Pharmaceuticals | COM | 75886F107 | 12,407 | 36,030 | SH | SOLE | 36,030 | 0 | 0 | ||
ReShape Lifesciences Inc | COM | 761123108 | 1,143 | 788,194 | SH | SOLE | 788,194 | 0 | 0 | ||
Rigel Pharmaceuticals Inc | COM NEW | 766559603 | 1,302 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
Sage Therapeutics Inc | COM | 78667J108 | 11,346 | 70,496 | SH | SOLE | 70,496 | 0 | 0 | ||
Sangamo Therapeutics Inc | COM | 800677106 | 1,004 | 53,000 | SH | SOLE | 53,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 2,000 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
Seattle Genetics Inc | COM | 812578102 | 2,223 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
Shire plc | SPONSORED ADR | 82481R106 | 14,790 | 99,000 | SH | SOLE | 99,000 | 0 | 0 | ||
Spark Therapeutics Inc | COM | 84652J103 | 799 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
Spring Bk Pharmaceuticals Inc | COM | 849431101 | 1,091 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
Stemline Therapeutics Inc | COM | 85858C107 | 7,517 | 492,930 | SH | SOLE | 492,930 | 0 | 0 | ||
Supernus Pharmaceuticals Inc | COM | 868459108 | 959 | 20,953 | SH | SOLE | 20,953 | 0 | 0 | ||
Synergy Pharmaceuticals DEL | COM | 871639308 | 2,726 | 1,505,809 | SH | SOLE | 1,505,809 | 0 | 0 | ||
Tesaro Inc | COM | 881569107 | 1,217 | 21,300 | SH | SOLE | 21,300 | 0 | 0 | ||
Transenterix Inc | COM | 89366M201 | 1,503 | 889,082 | SH | SOLE | 889,082 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc | COM | 90400D108 | 2,090 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
Verastem Inc | COM | 92337C104 | 1,192 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COM | 92532F100 | 11,119 | 68,222 | SH | SOLE | 68,222 | 0 | 0 | ||
Viking Therapeutics Inc | COM | 92686J106 | 305 | 70,000 | SH | SOLE | 70,000 | 0 | 0 |